Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: results from the Actionable Genome Consortium.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 21, 2019
Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M-Positive Lung Cancer and Acquired Resistance to Osimertinib.
Journal: JAMA oncology
Published: August 04, 2018
Monitoring of Response and Resistance in Plasma of EGFR-Mutant Lung Cancer Using Droplet Digital PCR.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 03, 2018
False-Positive Plasma Genotyping Due to Clonal Hematopoiesis.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 17, 2018
Amplicon-based next-generation sequencing of plasma cell-free DNA for detection of driver and resistance mutations in advanced non-small cell lung cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 12, 2018
Discrimination of Germline EGFR T790M Mutations in Plasma Cell-Free DNA Allows Study of Prevalence Across 31,414 Cancer Patients.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 19, 2017
Multiparametric profiling of non-small-cell lung cancers reveals distinct immunophenotypes.
Journal: JCI insight
Published: October 05, 2016
A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR-Mutant Non-Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 13, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026